BALSALL COMMON & MERIDEN GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: M89016 | COVENTRY, CV7 7RW
Showing results 51-100 of 642
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Propranolol hydrochloride | 1,154 | 77.6K | £3.1K | +8.1% ▲ |
| Rivaroxaban | 1,133 | 33.5K | £23.4K | +85.2% ▲ |
| Felodipine | 1,129 | 37.8K | £5.8K | +90.1% ▲ |
| Senna | 1,109 | 57.2K | £1.3K | +84.3% ▲ |
| Mometasone furoate | 1,092 | 1,232 | £9.6K | +172.0% ▲ |
| Carbocisteine | 1,091 | 185.6K | £4.8K | +104.4% ▲ |
| Latanoprost | 1,041 | 20.7K | £6.6K | +114.5% ▲ |
| Docusate sodium | 1,027 | 110.5K | £8.2K | +177.0% ▲ |
| Codeine phosphate | 1,024 | 74.7K | £2.7K | +42.5% ▲ |
| Solifenacin | 989 | 32.3K | £1.2K | +107.3% ▲ |
| 984 | 131.1K | £4.7K | +107.4% ▲ | |
| Morphine sulfate | 979 | 113.8K | £5.0K | +49.3% ▲ |
| Bendroflumethiazide | 976 | 30.5K | £494 | +26.2% ▲ |
| Fluoxetine hydrochloride | 973 | 46.2K | £1.6K | -4.1% ▼ |
| Dapagliflozin | 969 | 27.8K | £34.5K | -22.6% ▼ |
| Sildenafil (Erectile Dysfunction) | 957 | 6,120 | £867 | +89.9% ▲ |
| Gabapentin | 955 | 107.3K | £8.1K | -4.4% ▼ |
| Isosorbide mononitrate | 954 | 28.4K | £3.8K | +44.3% ▲ |
| Naproxen | 920 | 38.9K | £1.7K | -6.8% ▼ |
| Progesterone | 875 | 69.6K | £13.2K | +109.0% ▲ |
| Gliclazide | 853 | 43.0K | £1.3K | +0.3% vs avg |
| Spironolactone | 815 | 21.2K | £1.7K | +51.2% ▲ |
| Estradiol | 814 | 19.8K | £10.7K | +201.7% ▲ |
| Montelukast | 803 | 25.5K | £1.2K | +17.3% ▲ |
| Cetirizine hydrochloride | 803 | 41.5K | £1.6K | +60.7% ▲ |
| Ispaghula husk | 785 | 42.4K | £7.4K | +495.9% ▲ |
| Lercanidipine hydrochloride | 777 | 24.9K | £3.0K | +25.8% ▲ |
| Nitrofurantoin | 765 | 10.9K | £5.0K | +60.3% ▲ |
| Insulin aspart | 757 | 4,286 | £29.4K | +98.8% ▲ |
| Doxycycline hyclate | 723 | 7,842 | £729 | +41.0% ▲ |
| Digoxin | 706 | 19.5K | £1.4K | +86.5% ▲ |
| Edoxaban | 706 | 20.9K | £34.8K | +0.8% vs avg |
| Quinine sulfate | 705 | 21.2K | £3.1K | +143.5% ▲ |
| Mebeverine hydrochloride | 698 | 58.4K | £4.3K | +124.8% ▲ |
| Estradiol with progestogen | 697 | 29.2K | £20.5K | +104.5% ▲ |
| Methotrexate | 696 | 13.0K | £8.5K | +113.8% ▲ |
| Mirabegron | 694 | 21.6K | £19.8K | +72.8% ▲ |
| Ferrous sulfate | 694 | 23.7K | £787 | +35.0% ▲ |
| Flucloxacillin sodium | 672 | 25.7K | £1.6K | +49.4% ▲ |
| Atenolol | 669 | 22.7K | £504 | +11.0% ▲ |
| Lamotrigine | 658 | 42.7K | £4.5K | +11.4% ▲ |
| Fluticasone propionate (Inhalation) | 652 | 756 | £16.9K | +68.5% ▲ |
| 651 | 6,375 | £1.9K | +211.5% ▲ | |
| Insulin glargine | 641 | 3,164 | £24.6K | +125.8% ▲ |
| Perindopril erbumine | 639 | 20.4K | £1.7K | +20.4% ▲ |
| Esomeprazole | 638 | 29.5K | £3.0K | +57.7% ▲ |
| 623 | 1,363 | £47.4K | +14.3% ▲ | |
| Pravastatin sodium | 614 | 19.5K | £915 | +89.1% ▲ |
| Duloxetine hydrochloride | 599 | 21.9K | £1.4K | -5.8% ▼ |
| Tramadol hydrochloride | 592 | 52.0K | £1.7K | -17.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.